News in brief - November 2013

Other new launches, licence changes and updates relevant to general practice.

Estriol is still available as a cream for the treatment of atrophic vaginitis (pictured) | SCIENCE PHOTO LIBRARY
Estriol is still available as a cream for the treatment of atrophic vaginitis (pictured) | SCIENCE PHOTO LIBRARY
  • Ortho-Gynest (estriol) pessaries have been discontinued.
  • Use of clopidogrel has been associated with a small number of cases of acquired haemophilia; however, the risk-benefit balance of the drug is unchanged.
  • The influenza vaccines Enzira (Pfizer), Fluvirin (Novartis) and Viroflu (Janssen-Cilag) are now available for the current flu season.
  • Travel vaccination advice for some countries, including rabies recommendations for Greece and Spain, has been updated.
  • Stelara (ustekinumab) is now licensed for the treatment of active psoriatic arthritis in adults unresponsive to DMARDs.
  • Ilaris (canakinumab) has been approved for use in patients with active systemic juvenile idiopathic arthritis aged 2 years and older.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

A woman wearing a white vest as a blue-gloved hand of a healthcare professional are seen injecting a vaccine.

'Nocebo' effect may cause two-thirds of COVID-19 vaccine reactions, study suggests

Two-thirds of adverse reactions reported with the COVID-19...

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...